Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.35818215 |
2 | L-phenylalanine catabolic process (GO:0006559) | 7.35818215 |
3 | L-phenylalanine metabolic process (GO:0006558) | 7.12772450 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.12772450 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 6.89315698 |
6 | indole-containing compound catabolic process (GO:0042436) | 6.47751780 |
7 | indolalkylamine catabolic process (GO:0046218) | 6.47751780 |
8 | tryptophan catabolic process (GO:0006569) | 6.47751780 |
9 | glyoxylate metabolic process (GO:0046487) | 6.37041919 |
10 | cysteine metabolic process (GO:0006534) | 6.14551375 |
11 | tryptophan metabolic process (GO:0006568) | 6.10976890 |
12 | kynurenine metabolic process (GO:0070189) | 6.00822416 |
13 | lysine catabolic process (GO:0006554) | 5.99450868 |
14 | lysine metabolic process (GO:0006553) | 5.99450868 |
15 | bile acid biosynthetic process (GO:0006699) | 5.65989624 |
16 | serine family amino acid catabolic process (GO:0009071) | 5.55317559 |
17 | urate metabolic process (GO:0046415) | 5.52546147 |
18 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.42670246 |
19 | homocysteine metabolic process (GO:0050667) | 5.36040278 |
20 | sulfur amino acid catabolic process (GO:0000098) | 5.27881009 |
21 | drug transmembrane transport (GO:0006855) | 5.23850299 |
22 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.17761709 |
23 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.15467737 |
24 | alpha-linolenic acid metabolic process (GO:0036109) | 5.11776804 |
25 | urea metabolic process (GO:0019627) | 5.11646583 |
26 | urea cycle (GO:0000050) | 5.11646583 |
27 | aromatic amino acid family metabolic process (GO:0009072) | 5.07807133 |
28 | amino-acid betaine metabolic process (GO:0006577) | 5.00774470 |
29 | serine family amino acid metabolic process (GO:0009069) | 4.80740305 |
30 | alpha-amino acid catabolic process (GO:1901606) | 4.80626096 |
31 | nitrogen cycle metabolic process (GO:0071941) | 4.75754910 |
32 | bile acid metabolic process (GO:0008206) | 4.75348979 |
33 | drug catabolic process (GO:0042737) | 4.71636718 |
34 | proteasome assembly (GO:0043248) | 4.65978803 |
35 | indolalkylamine metabolic process (GO:0006586) | 4.58484683 |
36 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.57454795 |
37 | protein carboxylation (GO:0018214) | 4.57395649 |
38 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.57395649 |
39 | complement activation, alternative pathway (GO:0006957) | 4.55873214 |
40 | negative regulation of fibrinolysis (GO:0051918) | 4.54104327 |
41 | glycine metabolic process (GO:0006544) | 4.53247802 |
42 | cellular amino acid catabolic process (GO:0009063) | 4.52252979 |
43 | regulation of protein activation cascade (GO:2000257) | 4.50556402 |
44 | tyrosine metabolic process (GO:0006570) | 4.49721744 |
45 | amine catabolic process (GO:0009310) | 4.48563525 |
46 | cellular biogenic amine catabolic process (GO:0042402) | 4.48563525 |
47 | cellular modified amino acid catabolic process (GO:0042219) | 4.47198793 |
48 | serine family amino acid biosynthetic process (GO:0009070) | 4.47007098 |
49 | high-density lipoprotein particle remodeling (GO:0034375) | 4.45653653 |
50 | cellular ketone body metabolic process (GO:0046950) | 4.44554036 |
51 | drug transport (GO:0015893) | 4.39979001 |
52 | short-chain fatty acid metabolic process (GO:0046459) | 4.38433083 |
53 | regulation of fibrinolysis (GO:0051917) | 4.35701777 |
54 | rRNA modification (GO:0000154) | 4.30781654 |
55 | glutamate metabolic process (GO:0006536) | 4.30164108 |
56 | exogenous drug catabolic process (GO:0042738) | 4.27321644 |
57 | cellular glucuronidation (GO:0052695) | 4.26309431 |
58 | benzene-containing compound metabolic process (GO:0042537) | 4.25938767 |
59 | regulation of complement activation (GO:0030449) | 4.24145303 |
60 | aspartate family amino acid catabolic process (GO:0009068) | 4.21272520 |
61 | acetyl-CoA metabolic process (GO:0006084) | 4.16886346 |
62 | coenzyme catabolic process (GO:0009109) | 4.16182356 |
63 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.11529760 |
64 | ATP synthesis coupled proton transport (GO:0015986) | 4.11529760 |
65 | regulation of triglyceride catabolic process (GO:0010896) | 4.08258269 |
66 | negative regulation of sterol transport (GO:0032372) | 4.06535422 |
67 | negative regulation of cholesterol transport (GO:0032375) | 4.06535422 |
68 | ethanol oxidation (GO:0006069) | 4.05058301 |
69 | triglyceride homeostasis (GO:0070328) | 4.04507282 |
70 | acylglycerol homeostasis (GO:0055090) | 4.04507282 |
71 | organic acid catabolic process (GO:0016054) | 4.01231602 |
72 | carboxylic acid catabolic process (GO:0046395) | 4.01231602 |
73 | respiratory electron transport chain (GO:0022904) | 4.01095200 |
74 | aldehyde catabolic process (GO:0046185) | 4.01088393 |
75 | 2-oxoglutarate metabolic process (GO:0006103) | 3.99343120 |
76 | valine metabolic process (GO:0006573) | 3.96749679 |
77 | fatty acid beta-oxidation (GO:0006635) | 3.96167355 |
78 | rRNA methylation (GO:0031167) | 3.95697416 |
79 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.95082842 |
80 | bile acid and bile salt transport (GO:0015721) | 3.94313959 |
81 | regulation of cholesterol esterification (GO:0010872) | 3.92812497 |
82 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.92341623 |
83 | electron transport chain (GO:0022900) | 3.90943231 |
84 | fatty acid oxidation (GO:0019395) | 3.90247715 |
85 | uronic acid metabolic process (GO:0006063) | 3.89696954 |
86 | glucuronate metabolic process (GO:0019585) | 3.89696954 |
87 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.88539439 |
88 | reverse cholesterol transport (GO:0043691) | 3.85722458 |
89 | protein-lipid complex remodeling (GO:0034368) | 3.85500820 |
90 | macromolecular complex remodeling (GO:0034367) | 3.85500820 |
91 | plasma lipoprotein particle remodeling (GO:0034369) | 3.85500820 |
92 | imidazole-containing compound metabolic process (GO:0052803) | 3.84351423 |
93 | ketone body metabolic process (GO:1902224) | 3.84067288 |
94 | lipid oxidation (GO:0034440) | 3.82905016 |
95 | carnitine metabolic process (GO:0009437) | 3.81063639 |
96 | respiratory chain complex IV assembly (GO:0008535) | 3.77760959 |
97 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.75838384 |
98 | chaperone-mediated protein transport (GO:0072321) | 3.74874008 |
99 | monocarboxylic acid catabolic process (GO:0072329) | 3.70888977 |
100 | branched-chain amino acid metabolic process (GO:0009081) | 3.70610883 |
101 | branched-chain amino acid catabolic process (GO:0009083) | 3.67988706 |
102 | fatty acid catabolic process (GO:0009062) | 3.67088599 |
103 | phospholipid efflux (GO:0033700) | 3.66689532 |
104 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.66081626 |
105 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.65425839 |
106 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.65109521 |
107 | arginine metabolic process (GO:0006525) | 3.64880431 |
108 | ribosome assembly (GO:0042255) | 3.63586162 |
109 | regulation of cholesterol homeostasis (GO:2000188) | 3.63352063 |
110 | plasma lipoprotein particle clearance (GO:0034381) | 3.63179223 |
111 | regulation of mitochondrial translation (GO:0070129) | 3.62430635 |
112 | response to mercury ion (GO:0046689) | 3.60632015 |
113 | transcription from mitochondrial promoter (GO:0006390) | 3.60583879 |
114 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.59932231 |
115 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.59932231 |
116 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.58688682 |
117 | regulation of bile acid biosynthetic process (GO:0070857) | 3.58161480 |
118 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.56855212 |
119 | CENP-A containing nucleosome assembly (GO:0034080) | 3.56533692 |
120 | drug metabolic process (GO:0017144) | 3.56116519 |
121 | NAD biosynthetic process (GO:0009435) | 3.54512931 |
122 | phospholipid homeostasis (GO:0055091) | 3.53146264 |
123 | protein complex biogenesis (GO:0070271) | 3.52320145 |
124 | flavonoid metabolic process (GO:0009812) | 3.47800569 |
125 | chromatin remodeling at centromere (GO:0031055) | 3.47581955 |
126 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.43084512 |
127 | purine nucleobase biosynthetic process (GO:0009113) | 3.42731465 |
128 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.41453264 |
129 | cytochrome complex assembly (GO:0017004) | 3.41281700 |
130 | ribosomal large subunit biogenesis (GO:0042273) | 3.40808703 |
131 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.39764490 |
132 | negative regulation of ligase activity (GO:0051352) | 3.39764490 |
133 | DNA replication checkpoint (GO:0000076) | 3.34181925 |
134 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.32584597 |
135 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.32584597 |
136 | establishment of integrated proviral latency (GO:0075713) | 3.28447448 |
137 | pseudouridine synthesis (GO:0001522) | 3.24736913 |
138 | mitochondrial RNA metabolic process (GO:0000959) | 3.21272876 |
139 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.19489672 |
140 | protein neddylation (GO:0045116) | 3.18816982 |
141 | cullin deneddylation (GO:0010388) | 3.18252042 |
142 | nucleobase biosynthetic process (GO:0046112) | 3.17599373 |
143 | protein K6-linked ubiquitination (GO:0085020) | 3.13104382 |
144 | mitotic metaphase plate congression (GO:0007080) | 3.11155468 |
145 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.10950614 |
146 | positive regulation of ligase activity (GO:0051351) | 3.10242138 |
147 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.06926874 |
148 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.06926874 |
149 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.06851180 |
150 | NADH dehydrogenase complex assembly (GO:0010257) | 3.06851180 |
151 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.06851180 |
152 | protein targeting to mitochondrion (GO:0006626) | 3.06511609 |
153 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.06225784 |
154 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.06225784 |
155 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.06225784 |
156 | tetrahydrofolate metabolic process (GO:0046653) | 3.00957883 |
157 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.98230989 |
158 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.98230989 |
159 | histone exchange (GO:0043486) | 2.93922959 |
160 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.91302271 |
161 | translation (GO:0006412) | 2.90231401 |
162 | metaphase plate congression (GO:0051310) | 2.90193656 |
163 | formation of translation preinitiation complex (GO:0001731) | 2.89415141 |
164 | protein deneddylation (GO:0000338) | 2.87103082 |
165 | xenobiotic catabolic process (GO:0042178) | 2.86527328 |
166 | oxidative phosphorylation (GO:0006119) | 2.86216345 |
167 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.84588071 |
168 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.83887715 |
169 | kinetochore organization (GO:0051383) | 2.83413542 |
170 | cellular component biogenesis (GO:0044085) | 2.82869275 |
171 | rRNA processing (GO:0006364) | 2.82814675 |
172 | protein localization to mitochondrion (GO:0070585) | 2.80795825 |
173 | tricarboxylic acid cycle (GO:0006099) | 2.79864095 |
174 | pteridine-containing compound metabolic process (GO:0042558) | 2.79821764 |
175 | daunorubicin metabolic process (GO:0044597) | 2.78919161 |
176 | polyketide metabolic process (GO:0030638) | 2.78919161 |
177 | doxorubicin metabolic process (GO:0044598) | 2.78919161 |
178 | regulation of ligase activity (GO:0051340) | 2.77686633 |
179 | IMP biosynthetic process (GO:0006188) | 2.76258066 |
180 | peptidyl-histidine modification (GO:0018202) | 2.75779621 |
181 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.74970272 |
182 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.74824603 |
183 | establishment of protein localization to mitochondrion (GO:0072655) | 2.74700693 |
184 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.73500896 |
185 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.73396610 |
186 | lactate metabolic process (GO:0006089) | 2.72348922 |
187 | L-methionine salvage (GO:0071267) | 2.72244683 |
188 | L-methionine biosynthetic process (GO:0071265) | 2.72244683 |
189 | amino acid salvage (GO:0043102) | 2.72244683 |
190 | termination of RNA polymerase III transcription (GO:0006386) | 2.72086086 |
191 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.72086086 |
192 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.71264891 |
193 | rRNA metabolic process (GO:0016072) | 2.69768858 |
194 | L-serine metabolic process (GO:0006563) | 2.69214313 |
195 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.68508665 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.18458910 |
2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.09331557 |
3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.76119330 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.24455137 |
5 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 5.32068122 |
6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.12554536 |
7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.84023160 |
8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.82411627 |
9 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.39123200 |
10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.06140012 |
11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.80956132 |
12 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.76401259 |
13 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.66973029 |
14 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.18592125 |
15 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.18474183 |
16 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.06695695 |
17 | ELK1_19687146_ChIP-ChIP_HELA_Human | 3.00986882 |
18 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.00430688 |
19 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.79152608 |
20 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.76003403 |
21 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.55928935 |
22 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.50196139 |
23 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.47310089 |
24 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.46287506 |
25 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.45405820 |
26 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.33769462 |
27 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.33661145 |
28 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.28143426 |
29 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.24421084 |
30 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.19839249 |
31 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.15739215 |
32 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.14351061 |
33 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.11253676 |
34 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.08577315 |
35 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.08391407 |
36 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.07704553 |
37 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.07294467 |
38 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 2.06798136 |
39 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.04999695 |
40 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.4340585 |
41 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.99024114 |
42 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.97834238 |
43 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.88307820 |
44 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.82987841 |
45 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.70685889 |
46 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.69623334 |
47 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.67912253 |
48 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.65445873 |
49 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.64161942 |
50 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.61301578 |
51 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.61094114 |
52 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.58996791 |
53 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.57705693 |
54 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.57434759 |
55 | GATA1_22025678_ChIP-Seq_K562_Human | 1.54047830 |
56 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.52280970 |
57 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.48909415 |
58 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.48247429 |
59 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.43753132 |
60 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.41946742 |
61 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.39657895 |
62 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.35977562 |
63 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.34405664 |
64 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.33334481 |
65 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.33256343 |
66 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.30902476 |
67 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.22722991 |
68 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.22686929 |
69 | EWS_26573619_Chip-Seq_HEK293_Human | 1.19735338 |
70 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.19554178 |
71 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.19245561 |
72 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.18817826 |
73 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.17099300 |
74 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.15923763 |
75 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.15151773 |
76 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.13557828 |
77 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.13298081 |
78 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.12329260 |
79 | FUS_26573619_Chip-Seq_HEK293_Human | 1.12032243 |
80 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.11657097 |
81 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.10352897 |
82 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.10296621 |
83 | VDR_22108803_ChIP-Seq_LS180_Human | 1.10261117 |
84 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.10254382 |
85 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.10221534 |
86 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.10178139 |
87 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.08263571 |
88 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.07421803 |
89 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.06494579 |
90 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.05188033 |
91 | * FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.04467310 |
92 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.03284562 |
93 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.03049294 |
94 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.02878762 |
95 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.02856283 |
96 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.01813324 |
97 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.00374942 |
98 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.00249081 |
99 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00049633 |
100 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.00004111 |
101 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.90206785 |
102 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.85261210 |
103 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.83654523 |
104 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.83410400 |
105 | * NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.82845556 |
106 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.82572433 |
107 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.82341795 |
108 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.82089312 |
109 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.82086010 |
110 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.81146676 |
111 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.80305916 |
112 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.77778232 |
113 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.77560993 |
114 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.77184144 |
115 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.77178705 |
116 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.76577001 |
117 | * SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.76503243 |
118 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.76418263 |
119 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.76317171 |
120 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.76231280 |
121 | * PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.75961464 |
122 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.75447918 |
123 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.72998091 |
124 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.71678573 |
125 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.70962930 |
126 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.69227675 |
127 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.69167591 |
128 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.69167591 |
129 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.68866164 |
130 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.68516480 |
131 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.67435529 |
132 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.67227167 |
133 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.66015979 |
134 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.63979563 |
135 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.63567301 |
136 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.62750705 |
137 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.61300368 |
138 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.59476400 |
139 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.59132786 |
140 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.58905492 |
141 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.58636872 |
142 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.58306682 |
143 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.56230711 |
144 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.56209779 |
145 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.55355065 |
146 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.54849829 |
147 | * POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.53678978 |
148 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.52994929 |
149 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.52994929 |
150 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.52640353 |
151 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.51613440 |
152 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.51231518 |
153 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.51134351 |
154 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.50331408 |
155 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.50280861 |
156 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.50139859 |
157 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.49347030 |
158 | CBP_21632823_ChIP-Seq_H3396_Human | 0.48666535 |
159 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.47317120 |
160 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.46282254 |
161 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.45993594 |
162 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.45747217 |
163 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.45113942 |
164 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.44655896 |
165 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.44459338 |
166 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.43404454 |
167 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.42749106 |
168 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.42571096 |
169 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.42557228 |
170 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.40964902 |
171 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.40516557 |
172 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.40259346 |
173 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.38769629 |
174 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.38118347 |
175 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.37888561 |
176 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.37742674 |
177 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.37729893 |
178 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.37488681 |
179 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.37041998 |
180 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.36968829 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 8.00872269 |
2 | MP0005360_urolithiasis | 7.96819678 |
3 | MP0005085_abnormal_gallbladder_physiolo | 5.88453585 |
4 | MP0005365_abnormal_bile_salt | 5.72870922 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.76215623 |
6 | MP0003806_abnormal_nucleotide_metabolis | 4.19603367 |
7 | MP0003252_abnormal_bile_duct | 3.85226267 |
8 | MP0005332_abnormal_amino_acid | 3.47053398 |
9 | MP0008058_abnormal_DNA_repair | 3.34448987 |
10 | MP0003195_calcinosis | 3.24779314 |
11 | MP0010094_abnormal_chromosome_stability | 3.23350207 |
12 | MP0003693_abnormal_embryo_hatching | 3.08838555 |
13 | MP0010329_abnormal_lipoprotein_level | 3.07898330 |
14 | MP0004019_abnormal_vitamin_homeostasis | 2.96455409 |
15 | MP0004957_abnormal_blastocyst_morpholog | 2.95859399 |
16 | MP0010234_abnormal_vibrissa_follicle | 2.88013730 |
17 | MP0009840_abnormal_foam_cell | 2.69621348 |
18 | MP0002138_abnormal_hepatobiliary_system | 2.59949789 |
19 | MP0005083_abnormal_biliary_tract | 2.52667274 |
20 | MP0003941_abnormal_skin_development | 2.44941891 |
21 | MP0003111_abnormal_nucleus_morphology | 2.43520739 |
22 | MP0008057_abnormal_DNA_replication | 2.41117593 |
23 | MP0001666_abnormal_nutrient_absorption | 2.39606784 |
24 | MP0002938_white_spotting | 2.27439997 |
25 | MP0003077_abnormal_cell_cycle | 2.26228924 |
26 | MP0003191_abnormal_cellular_cholesterol | 2.04821035 |
27 | MP0009643_abnormal_urine_homeostasis | 2.01470360 |
28 | MP0003786_premature_aging | 1.98734340 |
29 | MP0008007_abnormal_cellular_replicative | 1.96269080 |
30 | * MP0000609_abnormal_liver_physiology | 1.95900588 |
31 | MP0002118_abnormal_lipid_homeostasis | 1.94482378 |
32 | MP0005319_abnormal_enzyme/_coenzyme | 1.91075155 |
33 | MP0008932_abnormal_embryonic_tissue | 1.90823355 |
34 | MP0001764_abnormal_homeostasis | 1.73806236 |
35 | MP0003186_abnormal_redox_activity | 1.73153994 |
36 | MP0003950_abnormal_plasma_membrane | 1.68647333 |
37 | MP0002837_dystrophic_cardiac_calcinosis | 1.66054558 |
38 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.63969760 |
39 | MP0004043_abnormal_pH_regulation | 1.59685821 |
40 | MP0000372_irregular_coat_pigmentation | 1.52371390 |
41 | MP0003868_abnormal_feces_composition | 1.51005895 |
42 | MP0005636_abnormal_mineral_homeostasis | 1.47068485 |
43 | MP0005451_abnormal_body_composition | 1.40968344 |
44 | MP0009697_abnormal_copulation | 1.40061928 |
45 | MP0000358_abnormal_cell_content/ | 1.31472602 |
46 | MP0005670_abnormal_white_adipose | 1.25894105 |
47 | MP0001756_abnormal_urination | 1.24280540 |
48 | MP0006072_abnormal_retinal_apoptosis | 1.22419497 |
49 | MP0002090_abnormal_vision | 1.15702429 |
50 | * MP0000598_abnormal_liver_morphology | 1.12380503 |
51 | MP0006036_abnormal_mitochondrial_physio | 1.12181409 |
52 | MP0004215_abnormal_myocardial_fiber | 1.11918020 |
53 | MP0002136_abnormal_kidney_physiology | 1.11421502 |
54 | MP0009764_decreased_sensitivity_to | 1.09577971 |
55 | MP0002638_abnormal_pupillary_reflex | 1.07475486 |
56 | MP0002160_abnormal_reproductive_system | 1.06763277 |
57 | MP0001697_abnormal_embryo_size | 1.04990306 |
58 | MP0005084_abnormal_gallbladder_morpholo | 1.04112146 |
59 | MP0002876_abnormal_thyroid_physiology | 1.02061487 |
60 | MP0005379_endocrine/exocrine_gland_phen | 1.01034998 |
61 | MP0005647_abnormal_sex_gland | 1.00403982 |
62 | MP0008877_abnormal_DNA_methylation | 0.99246304 |
63 | MP0005330_cardiomyopathy | 0.97696621 |
64 | MP0010307_abnormal_tumor_latency | 0.97689735 |
65 | MP0003011_delayed_dark_adaptation | 0.97497720 |
66 | MP0003705_abnormal_hypodermis_morpholog | 0.97285135 |
67 | MP0001730_embryonic_growth_arrest | 0.96641630 |
68 | MP0003656_abnormal_erythrocyte_physiolo | 0.95041911 |
69 | MP0008469_abnormal_protein_level | 0.93912037 |
70 | MP0001765_abnormal_ion_homeostasis | 0.91944325 |
71 | MP0010352_gastrointestinal_tract_polyps | 0.90852812 |
72 | MP0009763_increased_sensitivity_to | 0.90812697 |
73 | MP0000647_abnormal_sebaceous_gland | 0.89868278 |
74 | MP0009642_abnormal_blood_homeostasis | 0.89666993 |
75 | MP0000350_abnormal_cell_proliferation | 0.88878226 |
76 | MP0005408_hypopigmentation | 0.87484320 |
77 | MP0001929_abnormal_gametogenesis | 0.84661663 |
78 | MP0001661_extended_life_span | 0.84473314 |
79 | MP0001529_abnormal_vocalization | 0.83425300 |
80 | MP0005389_reproductive_system_phenotype | 0.83359541 |
81 | MP0003123_paternal_imprinting | 0.80771026 |
82 | MP0005058_abnormal_lysosome_morphology | 0.80451900 |
83 | MP0005220_abnormal_exocrine_pancreas | 0.80359686 |
84 | MP0001727_abnormal_embryo_implantation | 0.77427713 |
85 | MP0002102_abnormal_ear_morphology | 0.77104146 |
86 | MP0005535_abnormal_body_temperature | 0.76850825 |
87 | MP0002210_abnormal_sex_determination | 0.76715629 |
88 | MP0006292_abnormal_olfactory_placode | 0.76304749 |
89 | MP0005376_homeostasis/metabolism_phenot | 0.75335060 |
90 | MP0002078_abnormal_glucose_homeostasis | 0.74627991 |
91 | MP0005646_abnormal_pituitary_gland | 0.74444790 |
92 | MP0005410_abnormal_fertilization | 0.74200572 |
93 | MP0010678_abnormal_skin_adnexa | 0.74052203 |
94 | MP0000427_abnormal_hair_cycle | 0.74032415 |
95 | MP0002254_reproductive_system_inflammat | 0.73737751 |
96 | MP0001944_abnormal_pancreas_morphology | 0.73110885 |
97 | MP0006035_abnormal_mitochondrial_morpho | 0.72960923 |
98 | MP0005075_abnormal_melanosome_morpholog | 0.72704323 |
99 | MP0009765_abnormal_xenobiotic_induced | 0.72681519 |
100 | MP0000604_amyloidosis | 0.71198659 |
101 | MP0000613_abnormal_salivary_gland | 0.70018677 |
102 | MP0002877_abnormal_melanocyte_morpholog | 0.69800527 |
103 | * MP0000653_abnormal_sex_gland | 0.69653179 |
104 | MP0002928_abnormal_bile_duct | 0.69443751 |
105 | MP0005253_abnormal_eye_physiology | 0.69206887 |
106 | MP0005395_other_phenotype | 0.68685393 |
107 | MP0002971_abnormal_brown_adipose | 0.68094110 |
108 | MP0005666_abnormal_adipose_tissue | 0.65960024 |
109 | MP0003718_maternal_effect | 0.64610510 |
110 | * MP0001145_abnormal_male_reproductive | 0.64262943 |
111 | MP0001919_abnormal_reproductive_system | 0.64052846 |
112 | MP0005266_abnormal_metabolism | 0.63972487 |
113 | MP0000627_abnormal_mammary_gland | 0.62667038 |
114 | MP0002396_abnormal_hematopoietic_system | 0.61707506 |
115 | MP0003936_abnormal_reproductive_system | 0.60802253 |
116 | MP0002080_prenatal_lethality | 0.60417058 |
117 | MP0001186_pigmentation_phenotype | 0.59785433 |
118 | MP0010386_abnormal_urinary_bladder | 0.59462937 |
119 | MP0002095_abnormal_skin_pigmentation | 0.59366813 |
120 | MP0000313_abnormal_cell_death | 0.59025573 |
121 | MP0001672_abnormal_embryogenesis/_devel | 0.58443842 |
122 | MP0002168_other_aberrant_phenotype | 0.56951780 |
123 | MP0004130_abnormal_muscle_cell | 0.56728277 |
124 | * MP0005334_abnormal_fat_pad | 0.55604883 |
125 | MP0003724_increased_susceptibility_to | 0.54865810 |
126 | MP0003638_abnormal_response/metabolism_ | 0.54274408 |
127 | MP0010368_abnormal_lymphatic_system | 0.53747888 |
128 | MP0000230_abnormal_systemic_arterial | 0.48086413 |
129 | MP0004264_abnormal_extraembryonic_tissu | 0.47507397 |
130 | MP0002135_abnormal_kidney_morphology | 0.46516457 |
131 | MP0009053_abnormal_anal_canal | 0.44053388 |
132 | MP0004782_abnormal_surfactant_physiolog | 0.43747455 |
133 | MP0000538_abnormal_urinary_bladder | 0.43712879 |
134 | MP0003690_abnormal_glial_cell | 0.43067984 |
135 | MP0003953_abnormal_hormone_level | 0.43025303 |
136 | MP0002796_impaired_skin_barrier | 0.39370344 |
137 | MP0009672_abnormal_birth_weight | 0.39146406 |
138 | MP0008873_increased_physiological_sensi | 0.37311479 |
139 | MP0001845_abnormal_inflammatory_respons | 0.35736086 |
140 | MP0005448_abnormal_energy_balance | 0.35469397 |
141 | MP0009115_abnormal_fat_cell | 0.35011867 |
142 | MP0006082_CNS_inflammation | 0.34773749 |
143 | MP0005464_abnormal_platelet_physiology | 0.34531869 |
144 | MP0005166_decreased_susceptibility_to | 0.32594274 |
145 | MP0004147_increased_porphyrin_level | 0.31017826 |
146 | MP0003436_decreased_susceptibility_to | 0.29521597 |
147 | MP0001853_heart_inflammation | 0.29520456 |
148 | MP0000639_abnormal_adrenal_gland | 0.29013963 |
149 | MP0003329_amyloid_beta_deposits | 0.28893622 |
150 | MP0002970_abnormal_white_adipose | 0.28789290 |
151 | MP0003300_gastrointestinal_ulcer | 0.28622990 |
152 | MP0000371_diluted_coat_color | 0.27716725 |
153 | MP0008874_decreased_physiological_sensi | 0.26775216 |
154 | MP0003959_abnormal_lean_body | 0.25617467 |
155 | MP0008872_abnormal_physiological_respon | 0.25580587 |
156 | MP0001881_abnormal_mammary_gland | 0.24501338 |
157 | MP0009384_cardiac_valve_regurgitation | 0.24109938 |
158 | MP0008961_abnormal_basal_metabolism | 0.23825955 |
159 | MP0003075_altered_response_to | 0.23314372 |
160 | MP0004381_abnormal_hair_follicle | 0.22586277 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.59205108 |
2 | Intrahepatic cholestasis (HP:0001406) | 6.45230300 |
3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.79585689 |
4 | Deep venous thrombosis (HP:0002625) | 5.61612562 |
5 | Acute necrotizing encephalopathy (HP:0006965) | 5.51929964 |
6 | Xanthomatosis (HP:0000991) | 5.44324404 |
7 | Hyperglycinuria (HP:0003108) | 5.13817706 |
8 | Prolonged partial thromboplastin time (HP:0003645) | 5.09128246 |
9 | Abnormal mitochondria in muscle tissue (HP:0008316) | 5.04295783 |
10 | Acute encephalopathy (HP:0006846) | 5.04187948 |
11 | Hypobetalipoproteinemia (HP:0003563) | 5.00888557 |
12 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.95338033 |
13 | Progressive macrocephaly (HP:0004481) | 4.86306810 |
14 | Hyperglycinemia (HP:0002154) | 4.85762384 |
15 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.75605503 |
16 | Abnormality of glycine metabolism (HP:0010895) | 4.75605503 |
17 | Hyperammonemia (HP:0001987) | 4.63195866 |
18 | Ketosis (HP:0001946) | 4.53295736 |
19 | Mitochondrial inheritance (HP:0001427) | 4.40939146 |
20 | Gout (HP:0001997) | 4.37780039 |
21 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.35450323 |
22 | Complement deficiency (HP:0004431) | 4.29150573 |
23 | Increased hepatocellular lipid droplets (HP:0006565) | 4.28176323 |
24 | Hyperlipoproteinemia (HP:0010980) | 4.27934510 |
25 | Increased CSF lactate (HP:0002490) | 4.27667914 |
26 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.21427527 |
27 | Joint hemorrhage (HP:0005261) | 3.93831909 |
28 | Hypoglycemic coma (HP:0001325) | 3.89749684 |
29 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.85648040 |
30 | Lipid accumulation in hepatocytes (HP:0006561) | 3.85252897 |
31 | Hypolipoproteinemia (HP:0010981) | 3.78077465 |
32 | Abnormality of purine metabolism (HP:0004352) | 3.77843181 |
33 | Ketoacidosis (HP:0001993) | 3.75423725 |
34 | Abnormality of nucleobase metabolism (HP:0010932) | 3.73744444 |
35 | Fat malabsorption (HP:0002630) | 3.72208847 |
36 | Epidermoid cyst (HP:0200040) | 3.70253402 |
37 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.65546970 |
38 | Abnormality of methionine metabolism (HP:0010901) | 3.65348986 |
39 | Hepatic necrosis (HP:0002605) | 3.61816054 |
40 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.54374673 |
41 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.54374673 |
42 | Proximal tubulopathy (HP:0000114) | 3.52370023 |
43 | Reduced antithrombin III activity (HP:0001976) | 3.50927441 |
44 | Delayed CNS myelination (HP:0002188) | 3.49297664 |
45 | Renal Fanconi syndrome (HP:0001994) | 3.49189350 |
46 | Abnormality of the common coagulation pathway (HP:0010990) | 3.48986401 |
47 | Type I transferrin isoform profile (HP:0003642) | 3.47866161 |
48 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.44387473 |
49 | Hepatocellular necrosis (HP:0001404) | 3.41222178 |
50 | Abnormality of serum amino acid levels (HP:0003112) | 3.35531357 |
51 | Generalized aminoaciduria (HP:0002909) | 3.33841239 |
52 | Hypoalphalipoproteinemia (HP:0003233) | 3.31810241 |
53 | Conjugated hyperbilirubinemia (HP:0002908) | 3.23252290 |
54 | Methylmalonic acidemia (HP:0002912) | 3.18673693 |
55 | Lactic acidosis (HP:0003128) | 3.18613441 |
56 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.17443339 |
57 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.17434907 |
58 | Abnormality of alanine metabolism (HP:0010916) | 3.17434907 |
59 | Hyperalaninemia (HP:0003348) | 3.17434907 |
60 | Increased purine levels (HP:0004368) | 3.16479905 |
61 | Hyperuricemia (HP:0002149) | 3.16479905 |
62 | 3-Methylglutaconic aciduria (HP:0003535) | 3.14992188 |
63 | Dicarboxylic aciduria (HP:0003215) | 3.13210910 |
64 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.13210910 |
65 | Abnormality of the intrinsic pathway (HP:0010989) | 3.13093136 |
66 | Abnormality of complement system (HP:0005339) | 3.09853993 |
67 | Metabolic acidosis (HP:0001942) | 3.07357139 |
68 | Respiratory failure (HP:0002878) | 3.04273040 |
69 | Vascular calcification (HP:0004934) | 3.00613531 |
70 | Alkalosis (HP:0001948) | 2.97860458 |
71 | Increased serum lactate (HP:0002151) | 2.97308295 |
72 | Hyperbilirubinemia (HP:0002904) | 2.96680445 |
73 | Lethargy (HP:0001254) | 2.95576405 |
74 | Exercise intolerance (HP:0003546) | 2.93686948 |
75 | Increased serum pyruvate (HP:0003542) | 2.86561895 |
76 | Hypercholesterolemia (HP:0003124) | 2.83742660 |
77 | Steatorrhea (HP:0002570) | 2.82696369 |
78 | Abnormality of glycolysis (HP:0004366) | 2.81042005 |
79 | Increased intramyocellular lipid droplets (HP:0012240) | 2.80603234 |
80 | Hepatocellular carcinoma (HP:0001402) | 2.80563778 |
81 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.71948348 |
82 | Abnormal protein glycosylation (HP:0012346) | 2.71948348 |
83 | Abnormal glycosylation (HP:0012345) | 2.71948348 |
84 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.71948348 |
85 | Cardiovascular calcification (HP:0011915) | 2.66359209 |
86 | Glycosuria (HP:0003076) | 2.65375521 |
87 | Abnormality of urine glucose concentration (HP:0011016) | 2.65375521 |
88 | Leukodystrophy (HP:0002415) | 2.62666757 |
89 | Megaloblastic anemia (HP:0001889) | 2.61826642 |
90 | Hydroxyprolinuria (HP:0003080) | 2.58654392 |
91 | Abnormality of proline metabolism (HP:0010907) | 2.58654392 |
92 | Exertional dyspnea (HP:0002875) | 2.57034784 |
93 | Malnutrition (HP:0004395) | 2.52139426 |
94 | Spastic diplegia (HP:0001264) | 2.50667237 |
95 | Irritability (HP:0000737) | 2.50016244 |
96 | Methylmalonic aciduria (HP:0012120) | 2.48884168 |
97 | Vomiting (HP:0002013) | 2.48283987 |
98 | Myocardial infarction (HP:0001658) | 2.47190543 |
99 | Cerebral edema (HP:0002181) | 2.43488546 |
100 | Rickets (HP:0002748) | 2.42692152 |
101 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.42347921 |
102 | Systemic lupus erythematosus (HP:0002725) | 2.42192591 |
103 | Enlarged kidneys (HP:0000105) | 2.39998176 |
104 | Hypokalemic alkalosis (HP:0001949) | 2.38981202 |
105 | Neonatal onset (HP:0003623) | 2.34537920 |
106 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.33901953 |
107 | Abnormality of the anterior horn cell (HP:0006802) | 2.31428536 |
108 | Degeneration of anterior horn cells (HP:0002398) | 2.31428536 |
109 | Sensorimotor neuropathy (HP:0007141) | 2.30540919 |
110 | Hypoglycemic seizures (HP:0002173) | 2.29858331 |
111 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.28573934 |
112 | Macrocytic anemia (HP:0001972) | 2.27590623 |
113 | Hyperactive renin-angiotensin system (HP:0000841) | 2.26756556 |
114 | Skin nodule (HP:0200036) | 2.26596769 |
115 | Abnormality of renal resorption (HP:0011038) | 2.26299724 |
116 | Late onset (HP:0003584) | 2.25206553 |
117 | Pancreatitis (HP:0001733) | 2.23949550 |
118 | CNS demyelination (HP:0007305) | 2.23384510 |
119 | Abnormality of vitamin B metabolism (HP:0004340) | 2.22216889 |
120 | Increased muscle lipid content (HP:0009058) | 2.22161704 |
121 | Increased circulating renin level (HP:0000848) | 2.20992133 |
122 | Hypochromic microcytic anemia (HP:0004840) | 2.20366375 |
123 | Nausea (HP:0002018) | 2.20103050 |
124 | Optic disc pallor (HP:0000543) | 2.20050994 |
125 | Palpitations (HP:0001962) | 2.17356954 |
126 | Abnormality of chromosome stability (HP:0003220) | 2.15971392 |
127 | Hypokinesia (HP:0002375) | 2.13839597 |
128 | Symptomatic seizures (HP:0011145) | 2.12026916 |
129 | Conjunctival hamartoma (HP:0100780) | 2.10772414 |
130 | Spontaneous abortion (HP:0005268) | 2.09559412 |
131 | Patchy hypopigmentation of hair (HP:0011365) | 2.07754783 |
132 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.06111096 |
133 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.05633482 |
134 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.04076914 |
135 | Nephrolithiasis (HP:0000787) | 2.04059546 |
136 | Neoplasm of the adrenal gland (HP:0100631) | 2.03838428 |
137 | Renal cortical cysts (HP:0000803) | 2.02904489 |
138 | Abnormal urine output (HP:0012590) | 2.02479208 |
139 | Birth length less than 3rd percentile (HP:0003561) | 2.02230325 |
140 | Metabolic alkalosis (HP:0200114) | 2.00962439 |
141 | Opisthotonus (HP:0002179) | 2.00013095 |
142 | Abnormality of vitamin metabolism (HP:0100508) | 1.97892186 |
143 | Chromsome breakage (HP:0040012) | 1.97366947 |
144 | Esophageal varix (HP:0002040) | 1.97306375 |
145 | Mitral stenosis (HP:0001718) | 1.95843823 |
146 | Confusion (HP:0001289) | 1.95537490 |
147 | Abnormal cartilage morphology (HP:0002763) | 1.95505845 |
148 | Glomerulonephritis (HP:0000099) | 1.94279999 |
149 | Homocystinuria (HP:0002156) | 1.93743419 |
150 | Abnormality of homocysteine metabolism (HP:0010919) | 1.93743419 |
151 | Hyperphosphaturia (HP:0003109) | 1.93273879 |
152 | Elevated alkaline phosphatase (HP:0003155) | 1.93070873 |
153 | Abnormality of chloride homeostasis (HP:0011422) | 1.91362885 |
154 | Polyuria (HP:0000103) | 1.90576335 |
155 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.90071555 |
156 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.89721711 |
157 | Brushfield spots (HP:0001088) | 1.89245821 |
158 | Hypomagnesemia (HP:0002917) | 1.89134395 |
159 | Abnormal gallbladder morphology (HP:0012437) | 1.88577672 |
160 | Abnormality of the preputium (HP:0100587) | 1.86899461 |
161 | X-linked dominant inheritance (HP:0001423) | 1.85615264 |
162 | Respiratory difficulties (HP:0002880) | 1.84292389 |
163 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.83891145 |
164 | Neuroendocrine neoplasm (HP:0100634) | 1.82274105 |
165 | Abnormal urine phosphate concentration (HP:0012599) | 1.79724148 |
166 | Microvesicular hepatic steatosis (HP:0001414) | 1.75140809 |
167 | Meckel diverticulum (HP:0002245) | 1.74512100 |
168 | Renal tubular dysfunction (HP:0000124) | 1.71966391 |
169 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.67072418 |
170 | Abnormality of the ileum (HP:0001549) | 1.66310968 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 7.18390781 |
2 | MST4 | 4.93160493 |
3 | EIF2AK3 | 3.81784111 |
4 | FGFR4 | 3.77351242 |
5 | WNK3 | 3.73389375 |
6 | WNK4 | 3.47892565 |
7 | SIK1 | 3.46097497 |
8 | ERN1 | 3.29630943 |
9 | BUB1 | 3.18863793 |
10 | OXSR1 | 2.78084186 |
11 | INSRR | 2.58562947 |
12 | STK38L | 2.52016178 |
13 | VRK2 | 2.51467750 |
14 | ERBB4 | 2.34828153 |
15 | CDC7 | 2.32955633 |
16 | MAP3K12 | 2.32827001 |
17 | TAOK3 | 2.25111029 |
18 | BRSK2 | 2.12874761 |
19 | WEE1 | 2.10819713 |
20 | MST1R | 2.02297926 |
21 | BMPR1B | 1.93484468 |
22 | PLK3 | 1.87815556 |
23 | NUAK1 | 1.82402695 |
24 | SRPK1 | 1.81664946 |
25 | TRIM28 | 1.81456255 |
26 | TSSK6 | 1.78330252 |
27 | MAPK11 | 1.74831490 |
28 | FLT3 | 1.71123238 |
29 | PLK4 | 1.69263841 |
30 | NEK1 | 1.64594871 |
31 | IRAK3 | 1.60826371 |
32 | NEK9 | 1.57393010 |
33 | PINK1 | 1.56442614 |
34 | NME1 | 1.56401151 |
35 | LATS1 | 1.54698662 |
36 | VRK1 | 1.51481393 |
37 | PIK3CG | 1.46938773 |
38 | PDK3 | 1.42515449 |
39 | PDK4 | 1.42515449 |
40 | TYK2 | 1.40825384 |
41 | ZAK | 1.36391573 |
42 | PLK1 | 1.33667341 |
43 | ERBB3 | 1.31541368 |
44 | ABL2 | 1.31367587 |
45 | FRK | 1.30256721 |
46 | PKN2 | 1.28224220 |
47 | PRKAA2 | 1.24062440 |
48 | MAP2K4 | 1.24002158 |
49 | MAP3K3 | 1.21027719 |
50 | MAP3K14 | 1.20733035 |
51 | PAK4 | 1.19422229 |
52 | MYLK | 1.19309143 |
53 | PDK2 | 1.13206359 |
54 | TAF1 | 1.11231381 |
55 | KDR | 1.10408756 |
56 | MAP2K3 | 1.05835677 |
57 | TNIK | 1.04828102 |
58 | BRSK1 | 1.04140458 |
59 | AURKB | 1.03279196 |
60 | MKNK2 | 1.03246319 |
61 | PTK6 | 1.02408813 |
62 | CCNB1 | 0.98864986 |
63 | JAK2 | 0.93831293 |
64 | TRIB3 | 0.93388002 |
65 | EPHA2 | 0.91877108 |
66 | LIMK1 | 0.91684800 |
67 | SGK3 | 0.90222139 |
68 | SGK494 | 0.89273197 |
69 | SGK223 | 0.89273197 |
70 | GRK6 | 0.87806348 |
71 | MAP3K7 | 0.86444384 |
72 | JAK1 | 0.84955372 |
73 | PRKAA1 | 0.84826994 |
74 | GSK3A | 0.84189042 |
75 | TIE1 | 0.84026192 |
76 | SGK2 | 0.83134486 |
77 | TGFBR2 | 0.82545819 |
78 | MKNK1 | 0.81748954 |
79 | STK39 | 0.80799027 |
80 | MET | 0.80013841 |
81 | TBK1 | 0.79835234 |
82 | PLK2 | 0.77713331 |
83 | PHKG2 | 0.77106369 |
84 | PHKG1 | 0.77106369 |
85 | CAMK1D | 0.77074405 |
86 | FER | 0.74797279 |
87 | CDK6 | 0.72092332 |
88 | PASK | 0.71441780 |
89 | DYRK1B | 0.71112017 |
90 | AKT3 | 0.70240103 |
91 | ATR | 0.68410547 |
92 | MAP4K2 | 0.67654545 |
93 | PRKCI | 0.65866226 |
94 | RPS6KB2 | 0.65152209 |
95 | EPHB1 | 0.63912939 |
96 | STK4 | 0.63032595 |
97 | PRKACG | 0.62208149 |
98 | PRKCZ | 0.61045992 |
99 | CSNK2A2 | 0.60098284 |
100 | MAPK4 | 0.58771986 |
101 | CDK7 | 0.58396133 |
102 | CSNK2A1 | 0.58337770 |
103 | ERBB2 | 0.56236619 |
104 | AURKA | 0.54981245 |
105 | IRAK1 | 0.53887050 |
106 | CSK | 0.53731177 |
107 | CHEK2 | 0.53230782 |
108 | MAP3K11 | 0.52841663 |
109 | MAPK15 | 0.52533068 |
110 | CHEK1 | 0.51776609 |
111 | ATM | 0.51677077 |
112 | BMPR2 | 0.51463533 |
113 | EIF2AK1 | 0.50930856 |
114 | MAP2K6 | 0.50330057 |
115 | STK38 | 0.49371638 |
116 | ARAF | 0.49281141 |
117 | FGFR2 | 0.48974594 |
118 | PDPK1 | 0.48974247 |
119 | CDK4 | 0.48887299 |
120 | PTK2 | 0.47316423 |
121 | GRK1 | 0.46920234 |
122 | STK16 | 0.46567902 |
123 | DAPK2 | 0.46121269 |
124 | BCR | 0.45827357 |
125 | CSNK1G3 | 0.45731946 |
126 | TAOK2 | 0.45376395 |
127 | PBK | 0.44548774 |
128 | NME2 | 0.44386468 |
129 | STK10 | 0.44304109 |
130 | OBSCN | 0.44165583 |
131 | PNCK | 0.42718754 |
132 | MAP3K5 | 0.42533723 |
133 | DAPK1 | 0.41414392 |
134 | MAPK12 | 0.41351584 |
135 | SCYL2 | 0.41304652 |
136 | ILK | 0.40877242 |
137 | IRAK2 | 0.39983957 |
138 | IKBKE | 0.39926028 |
139 | CDK9 | 0.38880665 |
140 | CSNK1G2 | 0.38444261 |
141 | ACVR1B | 0.38262265 |
142 | MTOR | 0.37793741 |
143 | PIM1 | 0.37780594 |
144 | PRKCE | 0.37192291 |
145 | STK3 | 0.35863465 |
146 | FGFR3 | 0.35690321 |
147 | CDK8 | 0.35665233 |
148 | TLK1 | 0.34948067 |
149 | MUSK | 0.34782410 |
150 | TESK1 | 0.34266495 |
151 | FGFR1 | 0.34008036 |
152 | IGF1R | 0.33850933 |
153 | PIM2 | 0.33308387 |
154 | CAMK2G | 0.32527047 |
155 | YES1 | 0.32082365 |
156 | CSF1R | 0.32026084 |
157 | AKT2 | 0.31326818 |
158 | STK24 | 0.31320330 |
159 | CSNK1E | 0.30156931 |
160 | NEK2 | 0.30152681 |
161 | MAPK7 | 0.29723152 |
162 | PDK1 | 0.28748747 |
163 | CHUK | 0.24426215 |
164 | EPHA3 | 0.24379561 |
165 | LRRK2 | 0.23477525 |
166 | CSNK1G1 | 0.22253590 |
167 | TTK | 0.21146316 |
168 | IKBKB | 0.20652117 |
169 | PRKCA | 0.19961604 |
170 | EIF2AK2 | 0.19711110 |
171 | PRKCD | 0.19611045 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.97989399 |
2 | Proteasome_Homo sapiens_hsa03050 | 3.69821698 |
3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.44164639 |
4 | Protein export_Homo sapiens_hsa03060 | 3.30965305 |
5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.15307578 |
6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.09041474 |
7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.03268892 |
8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.91291924 |
9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.74985327 |
10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.73675028 |
11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.68994959 |
12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.60064188 |
13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.59188303 |
14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.53137245 |
15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.51561977 |
16 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.44783979 |
17 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.42991448 |
18 | Parkinsons disease_Homo sapiens_hsa05012 | 2.41572349 |
19 | Mismatch repair_Homo sapiens_hsa03430 | 2.40308955 |
20 | Ribosome_Homo sapiens_hsa03010 | 2.39329216 |
21 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.37296246 |
22 | Peroxisome_Homo sapiens_hsa04146 | 2.31653325 |
23 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.18155444 |
24 | DNA replication_Homo sapiens_hsa03030 | 2.12591497 |
25 | Homologous recombination_Homo sapiens_hsa03440 | 2.08989055 |
26 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.95175332 |
27 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.90383332 |
28 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.89974085 |
29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.89768157 |
30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.87307484 |
31 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.81316648 |
32 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.80168982 |
33 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.79958399 |
34 | Histidine metabolism_Homo sapiens_hsa00340 | 1.77698033 |
35 | RNA polymerase_Homo sapiens_hsa03020 | 1.75639858 |
36 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.73373282 |
37 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.73208024 |
38 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.72526259 |
39 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.70397100 |
40 | Huntingtons disease_Homo sapiens_hsa05016 | 1.68907355 |
41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.67107681 |
42 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.65589697 |
43 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.63940226 |
44 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.62479745 |
45 | Alzheimers disease_Homo sapiens_hsa05010 | 1.61858042 |
46 | Retinol metabolism_Homo sapiens_hsa00830 | 1.53557628 |
47 | Bile secretion_Homo sapiens_hsa04976 | 1.47461792 |
48 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.47316258 |
49 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.47284329 |
50 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.41938336 |
51 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.41479240 |
52 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.40788929 |
53 | Basal transcription factors_Homo sapiens_hsa03022 | 1.37905686 |
54 | Carbon metabolism_Homo sapiens_hsa01200 | 1.35418948 |
55 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.35077165 |
56 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.33763573 |
57 | RNA transport_Homo sapiens_hsa03013 | 1.33525633 |
58 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.30415822 |
59 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.29347546 |
60 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.26508071 |
61 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.25456675 |
62 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.25123243 |
63 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.24990665 |
64 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.22798789 |
65 | Spliceosome_Homo sapiens_hsa03040 | 1.22118521 |
66 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.18681021 |
67 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.18268223 |
68 | Base excision repair_Homo sapiens_hsa03410 | 1.13000638 |
69 | RNA degradation_Homo sapiens_hsa03018 | 1.12061703 |
70 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.11435483 |
71 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.05047466 |
72 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.03849626 |
73 | ABC transporters_Homo sapiens_hsa02010 | 1.03546176 |
74 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.03219690 |
75 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.00688141 |
76 | Lysine degradation_Homo sapiens_hsa00310 | 0.97102106 |
77 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.94740483 |
78 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.92059352 |
79 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.91869169 |
80 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.91645232 |
81 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.90270438 |
82 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.89361156 |
83 | Sulfur relay system_Homo sapiens_hsa04122 | 0.84730114 |
84 | Purine metabolism_Homo sapiens_hsa00230 | 0.84024706 |
85 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.82708418 |
86 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.80869408 |
87 | Cell cycle_Homo sapiens_hsa04110 | 0.78065073 |
88 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.76865693 |
89 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.69596519 |
90 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.55797942 |
91 | Metabolic pathways_Homo sapiens_hsa01100 | 0.54658301 |
92 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.49324738 |
93 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.40699495 |
94 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.40680254 |
95 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.36984639 |
96 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.36601782 |
97 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.34517482 |
98 | Galactose metabolism_Homo sapiens_hsa00052 | 0.31426185 |
99 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.31284269 |
100 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.26955336 |
101 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.24712387 |
102 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.22972972 |
103 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.19414954 |
104 | Insulin resistance_Homo sapiens_hsa04931 | 0.18724285 |
105 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.18112014 |
106 | Prion diseases_Homo sapiens_hsa05020 | 0.15814978 |
107 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.11280266 |
108 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.10631883 |
109 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.09847840 |
110 | Other glycan degradation_Homo sapiens_hsa00511 | 0.08630847 |
111 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.05910158 |
112 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.02752630 |
113 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.01930919 |
114 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.01464094 |
115 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.01402025 |
116 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01123017 |
117 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.2172919 |
118 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | -0.2035324 |
119 | Collecting duct acid secretion_Homo sapiens_hsa04966 | -0.1969329 |
120 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1905642 |
121 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1837830 |
122 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1775011 |
123 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1680837 |
124 | Pyrimidine metabolism_Homo sapiens_hsa00240 | -0.1530161 |
125 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1516792 |
126 | Hepatitis C_Homo sapiens_hsa05160 | -0.1495928 |
127 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1337679 |
128 | Lysosome_Homo sapiens_hsa04142 | -0.0603056 |
129 | Mineral absorption_Homo sapiens_hsa04978 | -0.0254648 |
130 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0105878 |
131 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0076478 |